SAVE THE DATE!

You are invited to the next meeting of the
Minnesota Chemoprevention Consortium

Wednesday, October 28, 2020
12:30 – 3:00 p.m.

HOSTED ONLINE via ZOOM BY
THE HORMEL INSTITUTE
UNIVERSITY OF MINNESOTA

Register now at: z.umn.edu/MC2signup

Presentations at this meeting will include:

Welcoming Remarks
Robert Clarke, Ph.D., D.Sc.
Executive Director, The Hormel Institute, University of Minnesota

Mitotic Defects Underlying Pediatric Diffuse Midline Gliomas
Ted Hinchcliffe, Ph.D.
I.J. Holton Professor of Cell Biology, The Hormel Institute, University of Minnesota
Jann Sarkaria, M.D.
Professor of Radiation Oncology, Director of the Brain Tumor Patient-Derived Xenograft National Resource, and Head of the Translational Neuro-Oncology Laboratory, Mayo Clinic

AAV: From Almost a Virus to Clinical Drug
George Aslanidi, Ph.D.
I.J. Holton Associate Professor and Leader of Molecular Bioengineering and Vaccine Development Research Sections, The Hormel Institute, University of Minnesota
Kah Whye Peng, Ph.D.
Professor of Oncology, Department of Molecular Medicine, Mayo Clinic

Chemotherapy-induced Premature Ovarian Failure and Regenerative Potential of Mesenchymal Stem Cells
Ilana Chefetz Menaker, Ph.D.
Assistant Professor, Cancer Stem Cells and Necroptosis, The Hormel Institute, University of Minnesota